| Authors: |
Qiu Y; Biologics Research, Sanofi, Framingham, Massachusetts, USA Yu.Qiu@sanofi.com harry.kleanthous@gatesfoundation.org., Stegalkina S; Sanofi Pasteur, Cambridge, Massachusetts, USA., Zhang J; Sanofi Pasteur, Cambridge, Massachusetts, USA., Boudanova E; Biologics Research, Sanofi, Framingham, Massachusetts, USA., Park A; Biologics Research, Sanofi, Framingham, Massachusetts, USA., Zhou Y; Biologics Research, Sanofi, Framingham, Massachusetts, USA., Prabakaran P; Biologics Research, Sanofi, Framingham, Massachusetts, USA., Pougatcheva S; Sanofi Pasteur, Cambridge, Massachusetts, USA., Ustyugova IV; Sanofi Pasteur, Cambridge, Massachusetts, USA., Vogel TU; Sanofi Pasteur, Cambridge, Massachusetts, USA., Mundle ST; Sanofi Pasteur, Cambridge, Massachusetts, USA., Oomen R; Sanofi Pasteur, Cambridge, Massachusetts, USA., Delagrave S; Sanofi Pasteur, Cambridge, Massachusetts, USA., Ross TM; Center for Vaccines and Immunology, University of Georgia, Athens, Georgia, USA.; Department of Infectious Diseases, University of Georgia, Athens, Georgia, USA., Kleanthous H; Sanofi Pasteur, Cambridge, Massachusetts, USA Yu.Qiu@sanofi.com harry.kleanthous@gatesfoundation.org., Qiu H; Biologics Research, Sanofi, Framingham, Massachusetts, USA. |